全文获取类型
收费全文 | 10632篇 |
免费 | 745篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 428篇 |
妇产科学 | 281篇 |
基础医学 | 1569篇 |
口腔科学 | 146篇 |
临床医学 | 1441篇 |
内科学 | 2039篇 |
皮肤病学 | 167篇 |
神经病学 | 1160篇 |
特种医学 | 284篇 |
外科学 | 866篇 |
综合类 | 73篇 |
一般理论 | 125篇 |
预防医学 | 1043篇 |
眼科学 | 204篇 |
药学 | 627篇 |
中国医学 | 9篇 |
肿瘤学 | 868篇 |
出版年
2023年 | 90篇 |
2022年 | 96篇 |
2021年 | 234篇 |
2020年 | 163篇 |
2019年 | 244篇 |
2018年 | 299篇 |
2017年 | 212篇 |
2016年 | 253篇 |
2015年 | 261篇 |
2014年 | 345篇 |
2013年 | 520篇 |
2012年 | 726篇 |
2011年 | 743篇 |
2010年 | 416篇 |
2009年 | 365篇 |
2008年 | 722篇 |
2007年 | 665篇 |
2006年 | 630篇 |
2005年 | 661篇 |
2004年 | 582篇 |
2003年 | 516篇 |
2002年 | 487篇 |
2001年 | 130篇 |
2000年 | 115篇 |
1999年 | 125篇 |
1998年 | 119篇 |
1997年 | 102篇 |
1996年 | 97篇 |
1995年 | 95篇 |
1994年 | 74篇 |
1993年 | 74篇 |
1992年 | 75篇 |
1991年 | 85篇 |
1990年 | 81篇 |
1989年 | 87篇 |
1988年 | 67篇 |
1987年 | 57篇 |
1986年 | 80篇 |
1985年 | 76篇 |
1984年 | 54篇 |
1983年 | 43篇 |
1982年 | 43篇 |
1981年 | 52篇 |
1980年 | 40篇 |
1979年 | 33篇 |
1978年 | 28篇 |
1977年 | 28篇 |
1976年 | 35篇 |
1975年 | 23篇 |
1966年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
132.
Recent evidence suggest that antagonism of adenosine A2A receptors represent an alternative therapeutic approach to Parkinson's disease (PD). Coactivation of A2A and the glutamate subtype 5 metabotropic receptors (mGlu5) synergistically stimulates DARPP-32 phosphorylation and c-fos expression in the striatum. This study therefore tested the effects of a joint blockade of these receptors to alleviate the motor dysfunction in a rat model of PD. 6-Hydroxydopamine infusions in the striatum produced akinetic deficits in rats trained to release a lever after a stimulus in a reaction time (RT) task. At 2 weeks after the lesion, A2A and mGlu5 receptors selective antagonists 8-(3-chlorostyryl)caffeine (CSC) and 2-methyl-6-(phenylethynyl)-pyridine (MPEP) were administered daily for 3 weeks either as a single or joint treatment. Injections of CSC (1.25 mg/kg) and MPEP (1.5 mg/kg) separately or in combination reduced the increase of delayed responses and RTs induced by 6-OHDA lesions, while the same treatment had no effect in controls. Furthermore, coadministration of lower doses of 0.625 mg/kg CSC and 0.375 mg/kg MPEP noneffective as a single treatment promoted a full and immediate recovery of akinesia, which was found to be more efficient than the separate blockade of these receptors. These results demonstrate that the combined inactivation of A2A and mGlu5 receptor potentiate their beneficial effects supporting this pharmacological strategy as a promising anti-Parkinsonian therapy. 相似文献
133.
Sampling designs dictated by stereology have proven very useful in recent years to estimate in situ the total number of deposited particles, or of macrophages, in different lung compartments at the light microscopical level. The sampling methods are based on parallel slabs which are subsequently subsampled by disectors. The resulting number estimators are unbiased irrespective of tissue shrinkage or swelling, and they are readily applicable in other contexts (notably in neuroscience). Several variants of the design are available, however, and, although they all yield the same number estimates, their precision, and the mathematical prediction of it, vary among the different estimators and are subjected to theoretical improvement. The present paper constitutes a detailed survey of the latest advances, and it illustrates methods and formulae alike by way of a real example stemming from an earlier study on particle retention and clearance. 相似文献
134.
135.
136.
Desestret V Ciccarino P Ducray F Crinière E Boisselier B Labussière M Polivka M Idbaih A Kaloshi G von Deimling A Hoang-Xuan K Delattre JY Mokhtari K Sanson M 《Journal of neuro-oncology》2011,105(2):219-224
Gliomatosis cerebri (GC) constitutes a heterogeneous group of conditions involving diffuse neoplastic glial cell infiltration of the brain. Management is difficult and an obvious challenge is to identify prognostic factors. Alpha-internexin (INA) expression, which is closely related to the 1p19q codeletion, is a strong prognostic marker in oligodendroglial tumors. Similarly, the R132H isocitrate dehydrogenase 1 IDH1 mutation, which can now be detected by use of a specific antibody, predicts better outcome in gliomas. In a retrospective series of 40 GC treated with up-front chemotherapy, we analyzed IDH1(R132H) mutant protein and INA immunohistochemical expression and correlated it with outcome; 17/40 GC expressed IDH1(R132H) and 10/40 GC expressed INA. IDH1(R132H) staining was strongly related to progression-free survival (42.3 vs. 15.5 months for positive IDH1(R132H) vs. negative tumors; P < 0.0001) and overall survival (73.9 vs. 23.6 months; P < 0.0001). This effect was independent of grade, histologic subtype, and INA expression (P < 0.001). Combined expression of IDH1(R132H) and INA was strongly associated with response to chemotherapy (100% vs. 36%; P = 0.003). These data strongly suggest that INA and IDH1(R132H) mutant protein immunohistochemical analysis is of a great prognostic value in biopsied GC. 相似文献
137.
von Minckwitz G Darb-Esfahani S Loibl S Huober J Tesch H Solbach C Holms F Eidtmann H Dietrich K Just M Clemens MR Hanusch C Schrader I Henschen S Hoffmann G Tiemann K Diebold K Untch M Denkert C 《Breast cancer research and treatment》2012,132(3):863-870
Adjacent ductal carcinoma in situ (DCIS) is found in approximately 45% of invasive ductal carcinomas (IDC) of the breast. Pure DCIS overexpresses HER2 in approximately 45%. There is uncertainty whether adjacent DCIS impacts on the response to neoadjuvant chemotherapy and trastuzumab as well as whether HER2 expression in IDC component or adjacent DCIS changes throughout treatment. Core biopsies and surgical tissue from participants of the GeparQuattro study with HER2-positive IDC were centrally examined for the area of invasive ductal component and adjacent DCIS before and after receiving neoadjuvant anthracycline?Ctaxane?Ctrastuzumab containing chemotherapy. HER2 overexpression in IDC and adjacent DCIS was quantified separately by immunohistochemistry using the Ventana? automated staining system. Pathological complete response (pCR) was defined as no residual invasive or non-invasive tumor tissue. Fifty-nine (37.3%) of 158 IDCs presented with adjacent DCIS at diagnosis. These tumors showed lower regression grades than pure IDC (P?=?0.033). The presence of adjacent DCIS was an independent negative predictor of pCR [odds ratio 0.42 (95% CI 0.2?C0.9), P?=?0.027]. Adjacent DCIS area decreased from pre-treatment to surgery (r?=?0.205) with 30 (50.8%) IDCs with adjacent DCIS showing complete eradication of adjacent DCIS. HER2 status of adjacent DCIS was highly correlated with HER2 status of IDC component before (r?=?0.892) and after treatment (r?=?0.676). Degree of HER2 overexpression of the IDC component decreased in 16 (33.3%) out of 49 patients without a pCR. These 16 IDCs showed lower RGs compared to the 33 IDCs with unchanged HER2 expression (P?=?0.055). HER2-positive IDCs with adjacent DCIS is less responsive to neoadjuvant chemotherapy and trastuzumab compared to pure IDC. However, complete eradication of adjacent DCIS is frequently observed. HER2-overexpression of the invasive ductal component decreases in a subset of tumors, which showed less tumor regression. 相似文献
138.
Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non‐Codeleted and IDH‐Mutated Gliomas 下载免费PDF全文
139.
Angelica A. Palm Joakim Esbjrnsson Anders Kvist Fredrik Mnsson Antonio Biague Hans Norrgren Marianne Jansson Patrik Medstrand 《Viruses》2022,14(11)
Limited data are available on the pathogenesis of HIV-2, and the evolution of Env molecular properties during disease progression is not fully elucidated. We investigated the intra-patient evolution of molecular properties of HIV-2 Env regions (V1–C3) during the asymptomatic, treatment-naïve phase of the infection in 16 study participants, stratified into faster or slower progressors. Most notably, the rate of change in the number of potential N-linked glycosylation sites (PNGS) within the Env (V1–C3) regions differed between progressor groups. With declining CD4+ T-cell levels, slower progressors showed, on average, a decrease in the number of PNGSs, while faster progressors showed no significant change. Furthermore, diversity increased significantly with time in faster progressors, whereas no such change was observed in slower progressors. No differences were identified between the progressor groups in the evolution of length or charge of the analyzed Env regions. Predicted virus CXCR4 use was rare and did not emerge as a dominating viral population during the studied disease course (median 7.9 years, interquartile range [IQR]: 5.2–14.0) in either progressor groups. Further work building on our observations may explain molecular hallmarks of HIV-2 disease progression and differences in pathogenesis between HIV-1 and HIV-2. 相似文献
140.
Stavroula Anastasopoulou Rikke Linnemann Nielsen Bodil Als-Nielsen Joanna Banerjee Mats A. Eriksson Marianne Helenius Mats M. Heyman Inga Maria Johannsdottir Olafur Gisli Jonsson Stuart MacGregor Marion K. Mateos Chelsea Mayoh Sirje Mikkel Ida Hed Myrberg Riitta Niinimki Kjeld Schmiegelow Mervi Taskinen Goda Vaitkeviciene Anna Warnqvist Benjamin Wolthers Arja Harila-Saari Susanna Ranta 《Haematologica》2022,107(10):2318
Central nervous system (CNS) toxicity is common at diagnosis and during treatment of pediatric acute lymphoblastic leukemia (ALL). We studied CNS toxicity in 1,464 children aged 1.0–17.9 years, diagnosed with ALL and treated according to the Nordic Society of Pediatric Hematology and Oncology ALL2008 protocol. Genome-wide association studies, and a candidate single-nucleotide polymorphism (SNP; n=19) study were performed in 1,166 patients. Findings were validated in an independent Australian cohort of children with ALL (n=797) in whom two phenotypes were evaluated: diverse CNS toxicities (n=103) and methotrexate-related CNS toxicity (n=48). In total, 135/1,464 (9.2%) patients experienced CNS toxicity for a cumulative incidence of 8.7% (95% confidence interval: 7.31–10.20) at 12 months from diagnosis. Patients aged ≥10 years had a higher risk of CNS toxicity than had younger patients (16.3% vs. 7.4%; P<0.001). The most common CNS toxicities were posterior reversible encephalopathy syndrome (n=52, 43 with seizures), sinus venous thrombosis (n=28, 9 with seizures), and isolated seizures (n=16). The most significant SNP identified by the genome-wide association studies did not reach genomic significance (lowest P-value: 1.11x10-6), but several were annotated in genes regulating neuronal functions. In candidate SNP analysis, ATXN1 rs68082256, related to epilepsy, was associated with seizures in patients <10 years (P=0.01). ATXN1 rs68082256 was validated in the Australian cohort with diverse CNS toxicities (P=0.04). The role of ATXN1 as well as the novel SNP in neurotoxicity in pediatric ALL should be further explored. 相似文献